Patents by Inventor Sakamuri V. Reddy

Sakamuri V. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating agent for Paget's disease of bone
    Patent number: 7163933
    Abstract: To obtain a treating agent for Paget's disease of bone, there is provided a method of inhibiting expression of general transcription factor of steroid hormone receptor.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: January 16, 2007
    Assignee: Teijin Limited
    Inventors: Seiichi Ishizuka, Kazuya Takenouchi, Atsushi Imaizumi, Yasuhiro Oue, Noriyoshi Kurihara, Sakamuri V. Reddy, G. David Roodman
  • Use of vitamin d derivatives as bone resorption inhibitors
    Publication number: 20040019024
    Abstract: To obtain a bone resorption inhibitor or a treating agent for Paget's disease of bone, there are provided a method of inhibiting bone resorption, comprising administering to a patient a vitamin D antagonist; and a method for treating Paget's disease of bone, comprising administering to a patient a vitamin D antagonist.
    Type: Application
    Filed: August 4, 2003
    Publication date: January 29, 2004
    Inventors: Seiichi Ishizuka, Kazuya Takenouchi, Atsushi Imaizumi, Yasuhiro Oue, Noriyoshi Kurihara, Sakamuri V Reddy, G. David Roodman
  • Treating agent for Paget's disease of bone
    Publication number: 20030191094
    Abstract: To obtain a treating agent for Paget's disease of bone, there is provided a method of inhibiting expression of general transcription factor of steroid hormone receptor.
    Type: Application
    Filed: February 21, 2003
    Publication date: October 9, 2003
    Applicant: TEIJIN LIMITED
    Inventors: Seiichi Ishizuka, Kazuya Takenouchi, Atsushi Imaizumi, Yasuhiro Oue, Noriyoshi Kurihara, Sakamuri V. Reddy, G. David Roodman
  • Compositions and methods of use for osteoclast inhibitor factors
    Patent number: 5985832
    Abstract: It has been found that two proteins produced by human osteoclasts inhibit osteoclast formation in bone marrow cultures and inhibit bone resorption in a fetal long bone assay. One of the proteins is identical to an Ly6 gene family protein and homologous to the Sca2 antigen, Ly6A. The second, OIP-2, is a novel protein not previously identified. The discovery of the osteoclast inhibition property of the OIP proteins suggests the therapeutic potential for patients with disordered osteoclast activity in such conditions as osteoporosis.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: November 16, 1999
    Assignee: Board of Regents, The University of Texas System
    Inventors: G. David Roodman, Sakamuri V. Reddy, Sun-Jin Choi